ABVC BioPharma, Inc.

ABVC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$864$717$1,392$5,829
Short-Term Investments$65$79$76$108
Receivables$1,155$760$1,369$426
Inventory$0$0$0$26
Other Curr. Assets$96$101$150$1,265
Total Curr. Assets$2,180$1,657$2,987$7,654
Property Plant & Equip (Net)$1,151$1,379$1,735$1,998
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,259$2,641$3,062$933
Tax Assets$0$0$117$0
Other NC Assets$1,950$2,108$3,033$3,114
Total NC Assets$5,360$6,128$7,947$6,044
Other Assets$0$0$0$0
Total Assets$7,540$7,784$10,934$13,698
Liabilities
Payables$0$0$0$0
Short-Term Debt$2,967$2,361$2,623$2,215
Tax Payable$0$113$0$0
Deferred Revenue$81$80$11$0
Other Curr. Liab.$3,509$3,548$2,910$1,477
Total Curr. Liab.$6,557$6,102$5,544$3,692
LT Debt$237$407$792$1,125
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$22$22$8$11
Total NC Liab.$258$429$800$1,135
Other Liabilities$0$0$0$0
Cap. Leases$237$407$792$1,472
Total Liabilities$6,816$6,531$6,343$4,828
Equity
Pref Stock$0$0$0$0
Common Stock$14$8$3$29
Retained Earnings-$68,950-$64,047-$54,904-$38,481
AOCI$477$516$517-$1,718
Other Equity$69,685$65,077$58,837$49,014
Total Equity$1,226$1,554$4,453$8,844
Supplemental Information
Minority Interest-$502-$301$138$27
Total Liab. & Tot. Equity$7,540$7,784$10,934$13,698
Net Debt$2,340$2,052$2,023-$2,489